Differential impact of resilience on demoralization and depression in Parkinson disease

Objectives The objective of this study was to study the interrelations of demoralization, depression, and resilience in patients with Parkinson disease, and, more specifically, to determine if higher resilience in patients with Parkinson disease is associated with lower demoralization, lower depression, or both. Methods Outpatients with Parkinson disease (N = 95) were assessed for demoralization, depression, and resilience, as well as sociodemographic, clinical, and treatment-related variables. Bivariable associations, standard regressions, linear regression with copula correction, and correspondence analysis were used to analyze the data. Results Although the bivariable association between resilience and depression was statistically significant, the association ceased to be significant when demoralization was taken into consideration in both standard regressions and linear regression with copula correction. By contrast, the association between resilience and demoralization was significant when depression was not taken into consideration and continued to be significant when depression was taken into consideration. Correspondence analysis revealed that low resilience was strongly related to demoralization combined with depression, whereas normal resilience was closely correlated with depression without demoralization. Conclusion These results expand our understanding of resilience by suggesting that it is a mechanism evolved to reduce or prevent demoralization and not just depression. Reducing demoralization and strengthening resilience as part of a comprehensive treatment plan are likely to improve the prognosis of Parkinson disease.

[1]  S. K. Van Den Eeden,et al.  Incidence of Parkinson disease in North America , 2022, NPJ Parkinson's disease.

[2]  P. Wilmes,et al.  Disease Progression, Resilience, and Inflammation Markers During the Coronavirus Disease 2019 Pandemic in Parkinson's Disease , 2022, Movement disorders : official journal of the Movement Disorder Society.

[3]  W. C. Chan,et al.  Prevalence and factors associated with demoralization in palliative care patients: A cross-sectional study from Hong Kong. , 2022, Palliative & supportive care.

[4]  J. de Figueiredo,et al.  From Perceived Stress to Demoralization in Parkinson Disease: A Path Analysis , 2022, Frontiers in Psychiatry.

[5]  G. Serafini,et al.  Demoralization in suicide: A systematic review. , 2022, Journal of psychosomatic research.

[6]  I. Leroi,et al.  Resilience in People with Lewy Body Disorders and Their Care Partners: Association with Mental Health, Relationship Satisfaction, and Care Burden , 2022, Brain sciences.

[7]  I. Chi,et al.  Effectiveness of Resilience Interventions on Psychosocial Outcomes for Persons With Neurocognitive Disorders: A Systematic Review and Meta-Analysis , 2021, Frontiers in Psychiatry.

[8]  P. Barone,et al.  Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic , 2021, Journal of movement disorders.

[9]  S. Ross,et al.  Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer. , 2021, ACS pharmacology & translational science.

[10]  J. de Figueiredo,et al.  Demoralization and Quality of Life of Patients with Parkinson Disease , 2021, Psychotherapy and Psychosomatics.

[11]  Yung-Yee Chang,et al.  A dyadic study of psychological well-being of individuals with Parkinson’s disease and their caregivers , 2021, Scientific reports.

[12]  A. Elbaz,et al.  Risk of Suicide Among Patients With Parkinson Disease. , 2020, JAMA psychiatry.

[13]  G. Fava,et al.  Sequential Combination of Cognitive-Behavioral Treatment and Well-Being Therapy in Depressed Patients with Acute Coronary Syndromes: A Randomized Controlled Trial (TREATED-ACS Study) , 2020, Psychotherapy and Psychosomatics.

[14]  E. Louis,et al.  Suicidal risk and demoralization in Parkinson disease , 2019, Journal of Neurology.

[15]  J. Maltby,et al.  Literature Review: Psychological Resilience Factors in People with Neurodegenerative Diseases. , 2019, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[16]  A Alexander Beaujean Path Analysis , 2019, The Blackwell Encyclopedia of Sociology.

[17]  G. Fava,et al.  Iatrogenic Factors in Psychopathology , 2019, Psychotherapy and Psychosomatics.

[18]  T. Osicka,et al.  Meaning and Purpose (MaP) therapy II: Feasibility and acceptability from a pilot study in advanced cancer , 2019, Palliative and Supportive Care.

[19]  Se-Kang Kim,et al.  Exploratory Visual Inspection of Category Associations and Correlation Estimation in Multidimensional Subspaces , 2018, J. Classif..

[20]  C. Tanner,et al.  Prevalence of Parkinson’s disease across North America , 2018, npj Parkinson's Disease.

[21]  Vikram M. Kakade,et al.  Demoralization in Parkinson disease , 2018, Neurology.

[22]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[23]  A. Mehnert,et al.  The association of demoralization with mental disorders and suicidal ideation in patients with cancer , 2017, Cancer.

[24]  A. Rydall,et al.  Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients With Advanced Cancer , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  B. Rybarczyk,et al.  The roles of resilience and nonmotor symptoms in adjustment to Parkinson’s disease , 2016, Journal of health psychology.

[26]  E. Fox,et al.  A Cognitive Model of Psychological Resilience , 2016 .

[27]  D. Kissane,et al.  A Review of the Construct of Demoralization , 2016, The American journal of hospice & palliative care.

[28]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[29]  D. Kissane,et al.  A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. , 2015, Journal of pain and symptom management.

[30]  S. Southwick,et al.  Resilience definitions, theory, and challenges: interdisciplinary perspectives , 2014, European journal of psychotraumatology.

[31]  G. Fava,et al.  Demoralization: a systematic review on its clinical characterization , 2014, Psychological Medicine.

[32]  Rd RoyallDawnaMSc A Decade of Research , 2014 .

[33]  M. Rahimzadeh,et al.  Sample size calculation in medical studies , 2013, Gastroenterology and hepatology from bed to bench.

[34]  A. Farmer,et al.  SELF‐REPORT AND CLINICIAN‐RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER? , 2012, Depression and anxiety.

[35]  W. Weiner,et al.  What determines resilience in patients with Parkinson's disease? , 2012, Parkinsonism & related disorders.

[36]  A. Mehnert,et al.  Demoralization and depression in patients with advanced cancer: validation of the German version of the demoralization scale. , 2011, Journal of pain and symptom management.

[37]  J. Clarke,et al.  What is a systematic review? , 2011, Evidence Based Nursing.

[38]  D. Kuhn,et al.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of l-DOPA treatment , 2011, Neuroscience & Biobehavioral Reviews.

[39]  Han-Joon Kim,et al.  Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment , 2009, Journal of the Neurological Sciences.

[40]  Mingyao Li,et al.  Joint Regression Analysis of Correlated Data Using Gaussian Copulas , 2009, Biometrics.

[41]  V. Fung,et al.  Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone , 2009, Movement disorders : official journal of the Movement Disorder Society.

[42]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[43]  J. Griffith,et al.  Brief psychotherapy at the bedside: countering demoralization from medical illness. , 2005, Psychosomatics.

[44]  D. Kissane,et al.  The Demoralization Scale: A Report of its Development and Preliminary Validation , 2004, Journal of palliative care.

[45]  Marjan Jahanshahi,et al.  Young‐ versus older‐onset Parkinson's disease: Impact of disease and psychosocial consequences , 2003, Movement disorders : official journal of the Movement Disorder Society.

[46]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[47]  R A Steer,et al.  Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. , 2000, Journal of consulting and clinical psychology.

[48]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[49]  J. de Figueiredo,et al.  Subjective incompetence, the clinical hallmark of demoralization. , 1982, Comprehensive psychiatry.

[50]  M. Meehan,et al.  Persuasion and Healing: A Comparative Study of Psychotherapy , 1973 .

[51]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[52]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[53]  René Algesheimer,et al.  REndo: A Package to Address Endogeneity Without External Instrumental Variables , 2019 .

[54]  D. Kissane Diagnosis and treatment of demoralization , 2017 .

[55]  Interdisciplinary perspectives , 2017, Journal of Medicine and Life.

[56]  VL Purcărea Interdisciplinary perspectives , 2017, Journal of medicine and life.

[57]  Bruce W. Smith,et al.  The brief resilience scale: Assessing the ability to bounce back , 2008, International journal of behavioral medicine.

[58]  M. Fava,et al.  Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. , 2007, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[59]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[60]  M. Greenacre Correspondence analysis in practice , 1993 .

[61]  J. de Figueiredo Depression and demoralization: phenomenologic differences and research perspectives. , 1993, Comprehensive psychiatry.

[62]  W. Gibb,et al.  Occasional Review , 2022 .